Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Newegg Commerce Inc (NEGG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Newegg Commerce Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Newegg Commerce Inc trades at $10.79 (market cap $232.74M). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 36.4× Newegg Commerce Inc's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Newegg Commerce Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Newegg Commerce Inc for 14 Days on average.
| HNGE | NEGG | |
|---|---|---|
Market Cap | $8.48B | $232.74M |
Volume | 879,799 | 40,856 |
Sector | Health | Consumer Cyclical |
52-Week High | $105.14 | $92.74 |
52-Week Low | $31.17 | $10.61 |
Typical Hold Time | 0 Days | 14 Days |
Enterprise Value | $8.10B | $202.98M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
NEGG trades at $10.61, down 6.52% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported revenue of $1.44 billion in 2025 with a net loss of $4.88 million, though recent quarters have beaten EPS estimates. Valuation ratios show a low P/S of 0.17 but a P/E of 24.52, while cash flow trends indicate reliance on financing activities. Recent news highlights partnerships with Western Digital and Hewlett Packard Enterprise to support IT infrastructure.
The outlook is mixed: improving profitability and strategic partnerships offer upside, but persistent net losses, negative operating cash flow, and insider selling pose risks. Analyst consensus is Buy with a $7.75 price target, below the current price, suggesting cautious optimism amid operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Newegg Commerce Inc
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.
Read more on NEGG →
